It's sad to watch a company selling its soul. Medscape used to be a source of reasonably trustworthy medical information with a few drug company ads thrown in to help pay the bills. Gradually, however, the promise of ever increasing riches became too alluring. It began selling disease-specific "resource centers" to the highest bidder (see my prior post here), earning millions from companies keen to control which articles are fed to doctors believing they are receiving medical education. At least these resource centers have a pretense of legitimacy, and if you dig around you can usually find something of value.
How things have changed. Today when I opened my email's inbox I received an email from Medscape. On the subject line: "Reasons to Choose Lexapro First." Eloquent in its simplicity. When I opened the email, I received nothing more than an advertisement for Lexapro (pasted above).
Yes, it appears that Medscape has found a new buyer for its Depression Resource Center. Kaching.